G-CSF-Based Stem Cell Therapy for the Heart—Unresolved Issues Part A: Paracrine Actions, Mobilization, and Delivery
Version of Record online: 19 JUN 2007
Congestive Heart Failure
Volume 13, Issue 4, pages 221–227, July/August 2007
How to Cite
Kurdi, M. and Booz, G. W. (2007), G-CSF-Based Stem Cell Therapy for the Heart—Unresolved Issues Part A: Paracrine Actions, Mobilization, and Delivery. Congestive Heart Failure, 13: 221–227. doi: 10.1111/j.1527-5299.2007.07111.x
- Issue online: 30 JUL 2007
- Version of Record online: 19 JUN 2007
- 6Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation. 2006;113:1983–1992., , , et al.
- 7Intracoronary infusion of bone marrow-derived progenitor cells in acute myocardial infarction: a randomized, double-blind, placebo controlled multicenter trial (REPAIR-AMI). Circulation. 2005;112(suppl II):PII-3362., , , et al.
- 13Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial. Nat Clin Pract Cardiovasc Med. 2007;4(suppl 1):S106–S109., , .
- 15Circulating stem/progenitor cells in stable ischemic heart disease and acute coronary syndromes - relevant reparatory mechanism? Heart. 2007 Mar 29; [Epub ahead of print]., , , et al.
- 38Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J. 2007;153:237.e1–237.e8., , , et al.
- 41Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J. 2007;153:212.e1–212.e7., , , et al.